Genitourinary Radiology: Page 10

Blue Earth's Axumin agent added to EAU guidelines

By AuntMinnieEurope.com staff writers

Molecular imaging firm Blue Earth Diagnostics said that its Axumin PET imaging agent has been added to the European Association of Urology (EAU) 2019 Clinical Practice Guidelines in Oncology for Prostate Cancer.

April 16, 2019

SPL receives German OK to test Ferrotran MRI contrast

By AuntMinnieEurope.com staff writers

SPL Medical of the Netherlands has received approval in Germany to test its Ferrotran (ferumoxtran-10) MRI contrast agent in a clinical trial.

March 25, 2019

Ga-68 PMSA PET/CT tops for prostate cancer recurrence

By Wayne Forrest

PET/CT with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) should be the choice over whole-body-MRI for detecting prostate cancer recurrence after radical prostatectomy, a German group advocates in a study published by the European Journal of Nuclear Medicine and Molecular Imaging.

March 24, 2019

Standardized accreditation is key for prostate MRI

By Edna Astbury-Ward, PhD

Quality in imaging is never guaranteed -- that is why working toward European-wide accreditation for prostate MRI is the way forward, expert speakers explained at this morning's ECR Master Class. Benchmarking quality in acquisition and reporting must be set within clear clinical pathways, and it is a vital part of the accreditation process.

March 2, 2019

Ga-68 PSMA-11 PET/MRI improves prostate cancer detection

By Wayne Forrest

VIENNA - PET/MRI with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) could become a valuable tool in image-guided biopsy and for detecting significant prostate cancer, researchers reported on Wednesday at ECR 2019.

February 28, 2019

Prostatic artery embolization gains clinical momentum

By Dr. Jamal Al Deen Alkoteesh

Prostate artery embolization has emerged as a highly promising interventional radiology procedure for lower urinary tract symptoms secondary to benign prostatic hypertrophy, Dr. Jamal Al Deen Alkoteesh told Arab Health delegates on the final day of the Total Radiology conference in Dubai, United Arab Emirates.

January 31, 2019

FDG-PET/CT improves bladder cancer staging

By Wayne Forrest

Combining metabolic and morphologic data from FDG-PET/CT scans can significantly improve the detection of lymph node metastasis in patients with muscle-invasive bladder cancer before their surgery, according to a French study published online on 21 January in European Radiology.

January 30, 2019

Curium, Progenics partner on PET agent in Europe

By AuntMinnieEurope.com staff writers

Global nuclear medicine firm Curium has joined Progenics Pharmaceuticals in an exclusive agreement to develop and commercialize Progenics' prostate-specific membrane antigen-targeted small molecule PET/CT imaging agent in Europe.

January 2, 2019

U.K. regulator recommends prostate MRI before biopsy

By Philip Ward

The National Institute for Health and Care Excellence in the U.K. has supported the use of multiparametric MRI as a frontline tool in English hospitals to scan for prostate cancer, but the Royal College of Radiologists has already expressed concerns over the shortage of equipment to cope with the additional examinations.

December 13, 2018

Ga-68 PSMA-11 PET/MRI benefits prostate cancer patients

By AuntMinnieEurope.com staff writers

PET/MRI with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) is on par with currently available tools for determining the risk of prostate cancer progression, according to a study published in the December issue of the Journal of Nuclear Medicine.

December 12, 2018

US/MRI fusion software enhances prostate biopsies

By Erik L. Ridley

Software that fuses ultrasound and MRI images for guidance of prostate biopsies can help surgeons find clinically significant prostate cancers that would have otherwise been missed, according to research published on 6 December in European Urology.

December 5, 2018

Intrasense debuts new lung, brain AI apps at RSNA 2018

By AuntMinnieEurope.com staff writers

French advanced visualization firm Intrasense is displaying new artificial intelligence (AI) applications for lung and brain imaging in collaboration with partners 12 Sigma Technologies and Quantib at RSNA 2018.

November 26, 2018

Previous Page

Page 10 of 22

Next Page